T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus

Gilead Sciences Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ed1cd473f1355f3a
Product Name: T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus
Artg Id: 371431
Artg Name: Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag
Sponsor: Gilead Sciences Pty Ltd
Company Detail Path: /organization/gilead-sciences-pty-limited
Artg Date: 2021-07-21
Registration Type: Biological
Therapeutic Good Type: Biological
Licence Status: A
Licence Category: INC
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/22570549d81e00e89615c3834d4ee139.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1b7af162538fc6f5d933989ca2f8e3b5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ed1cd473f1355f3a

Type

Standard